Theranostic approach to care of high risk solid tumors in pediatric age - pilot data
| Authors | |
|---|---|
| Year of publication | 2015 |
| Type | Conference abstract |
| MU Faculty or unit | |
| Citation | |
| Description | Development of targeted diagnostics and a number of new targeted drugs in oncology allows the design of an increasing number of patients personalized treatment based on knowledge of relevant biomarkers. The area that brings new hope to patients, but also new challenges and problems in this new modern diagnostics as well as therapy. |